Long-term culture of tumor-derived T cells in high-dose interleukin-2 (IL-2) allows for the generation of high numbers of TILs (>1 × 1011) but with preferential expansion of CD4+ lymphocytes [2-4]. The gene discussed is IL2; the disease is neoplasm.